Misplaced Pages

#164835

94-502: Specific Health Risks: Routes of contact for Diazinon include breathing it, consuming it, or contact with skin. The negative health effects when in contact with Diazinon includes eye watering, drool or runny nose, not having any appetite, throwing up, intense coughing, abdominal pain, or even stiffness in various muscles/paralysis. Headaches can also be health risks. Some other physiological effects include pinpoint pupils, increased heart rate, seizures, or even coma. Larger exposure to diazinon

188-552: A dyewood mill and a dye extraction plant. Two years later, they began the production of synthetic fuchsine. In 1901, they formed the public limited company Geigy, and the name of the company was changed to J. R. Geigy Ltd in 1914. CIBA and Geigy merged in 1970 to form Ciba‑Geigy Ltd. / ˌ s iː b ə ˈ ɡ aɪ ɡ i / . In the mid-1990s, state and federal health and environmental agencies identified an increased incidence of childhood cancers in Toms River, New Jersey , from

282-583: A thiophosphoric ester , shares a common mechanism of toxicity with other organophosphate insecticides such as chlorpyrifos , malathion and parathion , and is not very effective against the organophosphate-resistant insect populations. Symptoms of acute diazinon exposure develop in minutes to hours following exposure, depending on the exposure pathway. The initial symptoms of humans are nausea, dizziness, salivation, headache, sweating, lacrimation , and rhinorrhea . The symptoms can progress to vomiting, abdominal cramps, diarrhea, muscle twitching, weakness, tremor,

376-529: A 14-day period; or causes inflammation which lasts for 14 days in two test subjects. Mild skin irritation is minor damage (less severe than irritation) within 72 hours of application or for three consecutive days after application. Serious eye damage involves tissue damage or degradation of vision which does not fully reverse in 21 days. Eye irritation involves changes to the eye which do fully reverse within 21 days. An Environmental hazard can be defined as any condition, process, or state adversely affecting

470-511: A 15 percent stake in Gamida Cell for $ 35 million, with the option to purchase the whole company for approximately $ 165 million. In October 2014, Novartis announced its intention to sell its influenza vaccine business (inclusive of its development pipeline), subject to regulatory approval, to CSL for $ 275 million. In March 2015, the company announced BioPharma had completed its acquisition of two Phase III cancer-drug candidates;

564-432: A 47 percent premium. In March 2018, GlaxoSmithKline announced that it has reached an agreement with Novartis to acquire Novartis' 36.5 percent stake in their Consumer Healthcare Joint Venture for $ 13 billion (£9.2 billion). In April of the same year, the business utilised some of the proceeds from the aforementioned GlaxoSmithKline deal to acquire Avexis for $ 218 per share or $ 8.7 billion in total, gaining

658-422: A better subjective understanding of the schizophrenic experience, and many did exactly that and so did other scientific researchers. The Sandoz product received mass publicity as early as 1954, in a Time magazine feature. Research on LSD peaked in the 1950s and early 1960s. The CIA purchased quantities of LSD from Sandoz for use in its illegal human experimentation program known as MKUltra . Sandoz withdrew

752-401: A broad sense but are generally called pathogens rather than toxicants. The biological toxicity of pathogens can be difficult to measure because the threshold dose may be a single organism. Theoretically one virus , bacterium or worm can reproduce to cause a serious infection . If a host has an intact immune system , the inherent toxicity of the organism is balanced by the host's response;

846-522: A clinical-stage SK channel positive allosteric modulator. In September 2021, the company announced it would acquire gene-therapy business, Arctos Medical, broadening its optogenetics range. In December, Novartis announced it would purchase Gyroscope Therapeutics from health care investment company, Syncona Ltd, for up to $ 1.5 billion. In February 2022, New York City-based biotechnology company Cambrian Biopharma announced it had licensed rights to mTOR inhibitor programs from Novartis. As part of

940-424: A deeply rooted history of not only being aware of toxicity, but also taking advantage of it as a tool. Archaeologists studying bone arrows from caves of Southern Africa have noted the likelihood that some aging 72,000 to 80,000 years old were dipped in specially prepared poisons to increase their lethality. Although scientific instrumentation limitations make it difficult to prove concretely, archaeologists hypothesize

1034-477: A developer of technology for delivering RNA-based therapies, upfront for $ 500 million and an additional $ 500 million subject to reaching certain targets. Also in June, Novartis announced it would it would sell Xiidra to Bausch & Lomb for $ 1.75 billion and receive additional $ 750 million linked to future sales for Xiidra as well as two pipeline assets. In September 2023, Novartis announced that

SECTION 10

#1732855389165

1128-564: A fire broke out in a production plant storage room, which led to the Sandoz chemical spill and a large amount of pesticide being released into the upper Rhine river. This exposure killed many fish and other aquatic life. In 1995, Sandoz spun off its specialty chemicals business to form Clariant . In 1997, Clariant merged with the specialty chemicals business that was spun off from Hoechst AG in Germany. In 1996, Ciba-Geigy merged with Sandoz, with

1222-414: A given disorder (DiMascio, Soltys and Shader, 1970). These undesirable effects include anticholinergic effects, alpha-adrenergic blockade, and dopaminergic effects, among others. Toxicity can be measured by its effects on the target (organism, organ, tissue or cell). Because individuals typically have different levels of response to the same dose of a toxic substance, a population-level measure of toxicity

1316-547: A half-life of 2 to 6 weeks. Insects lack this hydrolysis step, which allows the toxic substance to accumulate rapidly; the detoxification of diazoxon is processed through the microsomal mixed function oxidase system. Although not fully understood, it is believed that this is the cause for the selectivity of diazinon against insects. After the hydrolysis or oxidation diazinon is broken down further (Reaction 4). To date, several methods such as electrochemistry, adsorption, enzymatic biodegradation, and photocatalysis have been tested for

1410-487: A hatter" and the "Mad Hatter" of the book Alice in Wonderland derive from the known occupational toxicity of hatters who used a toxic chemical for controlling the shape of hats. Exposure to chemicals in the workplace environment may be required for evaluation by industrial hygiene professionals. Hazards in the arts have been an issue for artists for centuries, even though the toxicity of their tools, methods, and materials

1504-412: A lack of coordination and miosis . Furthermore, some studies have even reported some psychiatric side effects including memory loss, confusion, and depression. Because diazinon is fat soluble, there is potential for delayed toxicity if significant amounts of diazinon are stored in fatty tissues. Intermediate syndrome generally occurs within 24–96 hours after exposure. Intermediate syndrome in humans

1598-449: A metabolite of diazinon) in molars . Molars from the two oldest subjects contained the largest concentrations of IMPy. And this concentration in molars may be a biomarker of perinatal exposure and during molar formation. Ciba-Geigy Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel , Switzerland. Consistently ranked in the global top five, Novartis

1692-529: A new company, Syngenta . In 2003, Novartis organized all its generics businesses into one division, and merged some of its subsidiaries into one company, reusing the predecessor brand name of Sandoz. In 2005, Novartis expanded its subsidiary Sandoz significantly through the US$ 8.29 billion acquisition of Hexal, one of Germany's leading generic drug companies, and Eon Labs, a fast-growing United States generic pharmaceutical company. In 2006, Novartis acquired

1786-722: A new method of non-toxic lithography . There are many environmental health mapping tools. TOXMAP is a Geographic Information System (GIS) from the Division of Specialized Information Services of the United States National Library of Medicine (NLM) that uses maps of the United States to help users visually explore data from the United States Environmental Protection Agency 's (EPA) Toxics Release Inventory and Superfund programs. TOXMAP

1880-472: A newly created subsidiary. Endocyte will bolster Novartis' offering in its radiopharmaceuticals business, with Endocyte's first in class candidate Lu-PSMA-617 being targeted against metastatic castration-resistant prostate cancer. In late December the company announced it would acquire France-based contract manufacturer, CellforCure from LFB , boosting its capacity to produce cell and gene therapies. On 9 April 2019, Novartis announced that it had completed

1974-399: A newly synthesized and previously unstudied chemical that is believed to be very similar in effect to another compound could be assigned an additional protection factor of 10 to account for possible differences in effects that are probably much smaller. This approach is very approximate, but such protection factors are deliberately very conservative, and the method has been found to be useful in

SECTION 20

#1732855389165

2068-487: A physical toxicant if taken in extremely high doses because the concentration of vital ions decreases dramatically with too much water in the body. Asphyxiant gases can be considered physical toxicants because they act by displacing oxygen in the environment but they are inert, not chemically toxic gases. Radiation can have a toxic effect on organisms. Behavioral toxicity refers to the undesirable effects of essentially therapeutic levels of medication clinically indicated for

2162-581: A strong foundation for our (Novartis') individualized treatment programs". In 2012, the Company cut approximately 2,000 positions in the United States, primarily in sales, in response to anticipated revenue downturns from the hypertension drug Diovan , which was losing patent protection, and the realization that the anticipated successor to Diovan, Rasilez , was failing in clinical trials. The 2012 personnel reductions follow ~2000 cut positions in Switzerland and

2256-552: A tougher pesticide law in 1996. Diazinon was banned from use as an agricultural insecticide. At the time 80% of United States could find Diazinon in their residential products. In fact it still may be in use in certain households, as it is still used and considered legal in 14 states including California. Yet with the ban starting in 2004, having had 20 years pass, states which have accepted that ban have had hardware stores and other suppliers report that they have "ran out" of products with diazinon. These states which continue to use Diazinon

2350-516: A toxic substance is safe for a laboratory rat, one might assume that one-tenth that dose would be safe for a human, allowing a safety factor of 10 to allow for interspecies differences between two mammals; if the data are from fish, one might use a factor of 100 to account for the greater difference between two chordate classes (fish and mammals). Similarly, an extra protection factor may be used for individuals believed to be more susceptible to toxic effects such as in pregnancy or with certain diseases. Or,

2444-400: A wide variety of applications. Assessing all aspects of the toxicity of cancer-causing agents involves additional issues, since it is not certain if there is a minimal effective dose for carcinogens , or whether the risk is just too small to see. In addition, it is possible that a single cell transformed into a cancer cell is all it takes to develop the full effect (the "one hit" theory). It

2538-410: Is a contact insecticide which kills insects by altering normal neurotransmission within the nervous system of the insect. As mentioned above, diazinon inhibits the enzyme acetylcholinesterase (AChE), which hydrolyzes the neurotransmitter acetylcholine (ACh) in cholinergic synapses and neuromuscular junctions . This results in abnormal accumulation of ACh within the nervous system. Diazinon, although

2632-751: Is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Biotechnology Innovation Organization (BIO), the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), and the Pharmaceutical Research and Manufacturers of America (PhRMA). Novartis is the third most valuable pharmaceutical company in Europe, after Novo Nordisk and Roche . Novartis

2726-584: Is a resource funded by the US Federal Government. TOXMAP's chemical and environmental health information is taken from NLM's Toxicology Data Network (TOXNET) and PubMed , and from other authoritative sources. Aquatic toxicity testing subjects key indicator species of fish or crustacea to certain concentrations of a substance in their environment to determine the lethality level. Fish are exposed for 96 hours while crustacea are exposed for 48 hours. While GHS does not define toxicity past 100 mg/L,

2820-442: Is already working on in 'real-life' situations". The deal will pursue solutions for "organizing and using" data generated from Novartis' laboratory experiments, clinical trials, and manufacturing plants. It will also look at improving manufacturing of Chimeric antigen receptor T cell (CAR T cells). Finally, the deal "will also apply AI to generative chemistry to enhance drug design". In November 2019, Sandoz announced it would acquire

2914-597: Is also eligible to receive up to $ 300 million dependent upon future marketing approval milestones outside of America and up to $ 400 million relating to sales milestones. In September 2014, Ophthotech received its first $ 50 million phase III trial milestone payment from Novartis. In April 2014, Novartis announced that it would acquire GlaxoSmithKline 's cancer drug business for $ 16 billion as well as selling its vaccines business to GlaxoSmithKline for $ 7.1 billion. In August 2014 Genetic Engineering & Biotechnology News reported that Novartis had acquired

Diazinon - Misplaced Pages Continue

3008-415: Is characterized by difficulty breathing and muscular weakness, often in the face, neck and proximal limb muscles. Cranial nerve palsies and depressed tendon reflexes have also been reported. Studies have suggested that exposure to some organophosphate pesticides can result in long-term neurological problems including organophosphate-induced delayed neuropathy (weakness or paralysis as well as paresthesia in

3102-440: Is incurred and how long it remains; whether it is reversible and how many test subjects were affected. Skin corrosion from a substance must penetrate through the epidermis into the dermis within four hours of application and must not reverse the damage within 14 days. Skin irritation shows damage less severe than corrosion if: the damage occurs within 72 hours of application; or for three consecutive days after application within

3196-499: Is known to yield these risks. If it is a smaller exposure, the symptoms may be reduced such as just a runny nose or some eye watering. One thing to note is that while Diazinon has many different health risks, the EPA has not categorized it as a carcinogen. Diazinon was developed in 1952 by the Swiss company Ciba-Geigy (now Novartis ) to replace the formerly dominant insecticide DDT . In 1939,

3290-543: Is more difficult to determine the toxicity of chemical mixtures than a pure chemical because each component displays its own toxicity, and components may interact to produce enhanced or diminished effects. Common mixtures include gasoline , cigarette smoke , and industrial waste . Even more complex are situations with more than one type of toxic entity, such as the discharge from a malfunctioning sewage treatment plant, with both chemical and biological agents. The preclinical toxicity testing on various biological systems reveals

3384-445: Is often used which relates the probabilities of an outcome for a given individual in a population. One such measure is the LD 50 . When such data does not exist, estimates are made by comparison to known similar toxic things, or to similar exposures in similar organisms. Then, " safety factors " are added to account for uncertainties in data and evaluation processes. For example, if a dose of

3478-502: Is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022. Novartis manufactures the drugs clozapine (Clozaril), diclofenac (Voltaren; sold to GlaxoSmithKline in 2015 deal), carbamazepine (Tegretol), valsartan (Diovan), imatinib mesylate (Gleevec/Glivec), cyclosporine (Neoral/Sandimmune), letrozole (Femara), methylphenidate (Ritalin; production ceased 2020), terbinafine (Lamisil), deferasirox (Exjade), and others. Novartis

3572-430: Is performed by the liver microsomal enzyme system and requires O 2 and NADPH . Diazinon can also be decomposed via oxidation in the liver (Reaction 2). Both reactions are possible, and likely are catalyzed nonspecifically by the same mixed function oxidase . Diazoxon is further broken down by hydrolases in the microsomal and other subcellular functions within the liver (Reaction 3). Mammals metabolize diazoxon with

3666-423: Is that the effects of a toxicant are dose -dependent; even water can lead to water intoxication when taken in too high a dose, whereas for even a very toxic substance such as snake venom there is a dose below which there is no detectable toxic effect. Toxicity is species-specific, making cross-species analysis problematic. Newer paradigms and metrics are evolving to bypass animal testing , while maintaining

3760-472: Is the degree to which a chemical substance or a particular mixture of substances can damage an organism . Toxicity can refer to the effect on a whole organism, such as an animal , bacterium , or plant , as well as the effect on a substructure of the organism, such as a cell ( cytotoxicity ) or an organ such as the liver ( hepatotoxicity ). Sometimes the word is more or less synonymous with poisoning in everyday usage. A central concept of toxicology

3854-484: Is the founder of Sandoz's pharmaceutical department in 1917. In 1918, Arthur Stoll isolated ergotamine from ergot ; the substance was eventually used to treat migraine and headaches and was introduced under the trade name Gynergen in 1921. Between the World Wars, Gynergen (1921) and Calcium-Sandoz (1929) were brought to market. Sandoz also produced chemicals for textiles, paper, and leather , beginning in 1929. In 1939,

Diazinon - Misplaced Pages Continue

3948-496: Is their products consider their risks low, yet its greatest affect is through inhalation and skin contact. Certain environmental groups continue to protest these states which still continue its use. Diazinon is considered to be of relatively high toxicity for vertebrates . The common method of administering diazinon is absorption although inhalation is possible as well. The observed toxification symptoms conform to other acetylcholinesterase inhibitors . Symptoms are as follows: On

4042-550: The CD20 monoclonal antibody Ofatumumab from GlaxoSmithKline for up to $ 1 billion. In October the company acquired Admune Therapeutics for an undisclosed sum, as well as licensing PBF-509 , an adenosine A2A receptor antagonist which is in Phase I clinical trials for non-small cell lung cancer, from Palobiofarma . In November 2016, the company announced it would acquire Selexys Pharmaceuticals for $ 665 million. In December,

4136-790: The Gerber Products Company to Nestlé as part of its continuing effort to shed old Sandoz and Ciba-Geigy businesses and focus on healthcare. In 2009, Novartis reached an agreement to acquire an 85 percent stake in the Chinese vaccines company Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. as part of a strategic initiative to build a vaccines industry leader in this country and expand the group's limited presence in this fast-growing market segment. This proposed acquisition will require government and regulatory approvals in China. In 2010, Novartis offered to pay US$ 39.3 billion to fully acquire Alcon ,

4230-497: The MEK inhibitor binimetinib (MEK 162) and the BRAF inhibitor encorafenib (LGX818), for $ 85 million. In addition, the company sold its RNAi portfolio to Arrowhead Research for $ 10 million and $ 25 million in stock. In June, the company announced it would acquire Spinifex Pharmaceuticals for more than $ 200 million. In August, the company acquired the remaining rights to

4324-531: The 1970–1995 period. Multiple investigations by state and federal environmental and health agencies indicated that the likely source of the increased cancer risk was contamination from Toms River Chemical Plant (then operated by Ciba-Geigy), which had been in operation since 1952, and the Reich Farm/Union Carbide. The area was designated a United States Environmental Protection Agency Superfund site in 1983 after an underground plume of toxic chemicals

4418-583: The California-based Chiron Corporation . Chiron had been divided into three units: Chiron Vaccines, Chiron Blood Testing, and Chiron BioPharmaceuticals. The biopharmaceutical unit was integrated into Novartis Pharmaceuticals, while the vaccines and blood testing units were made into a new Novartis Vaccines and Diagnostics division. Also in 2006, Sandoz became the first company to have a biosimilar drug approved in Europe with its recombinant human growth hormone drug. In 2007, Novartis sold

4512-411: The EPA currently lists aquatic toxicity as "practically non-toxic" in concentrations greater than 100 ppm. Note: A category 4 is established for chronic exposure, but simply contains any toxic substance which is mostly insoluble, or has no data for acute toxicity. Toxicity of a substance can be affected by many different factors, such as the pathway of administration (whether the toxicant is applied to

4606-607: The German chemical maker BASF . In 1998, the company entered into a biotechnology licensing agreement with the University of California at Berkeley Department of Plant and Microbial Biology . Critics of the agreement expressed concern over prospects that the agreement would diminish academic objectivity, or lead to the commercialization of genetically modified plants. The agreement expired in 2003. In 2000, Novartis and AstraZeneca combined their agrobusiness divisions to create

4700-545: The Japanese business of Aspen Global inc for €300 million (around $ 330 million), boosting the business's presence in Asia. In late November 2019, the business announced it would acquire The Medicines Company for US$ 9.7 billion ($ 85 per share) in order to acquire amongst other assets, the cholesterol lowering therapy; inclisiran . In April 2020, the company announced it would acquire Amblyotech. In September 2020, Novartis

4794-546: The No Observed Adverse Effect Level (NOAEL) dose and is helpful for clinical studies. For substances to be regulated and handled appropriately they must be properly classified and labelled. Classification is determined by approved testing measures or calculations and has determined cut-off levels set by governments and scientists (for example, no-observed-adverse-effect levels , threshold limit values , and tolerable daily intake levels). Pesticides provide

SECTION 50

#1732855389165

4888-737: The Novartis drugs. In October Novartis announced it would acquire Vedere Bio for $ 280 million boosting the businesses cell and gene therapy offerings. In October 2020, as part of a joint venture to develop therapeutic drugs to combat COVID-19 , Novartis bought 6% of all shares outstanding in Swiss DARPin research company Molecular Partners AG at CHF 23 per share. In December 2020, Novartis announced it would acquire Cadent Therapeutics for up to $ 770 million, gaining full rights to CAD-9303 (a NMDAr positive allosteric modulator ), MIJ-821 (a NMDAr negative allosteric modulator ) and CAD-1883

4982-556: The Toms River water system has been subject to the most stringent water testing in New Jersey and is considered safe for consumption. Dan Fagin 's Toms River: A Story of Science and Salvation , the 2014 Pulitzer Prize winning book, examined the issue of industrial pollution at the site in detail. Sandoz is the generic drugs division of Novartis. Before the 1996 merger with Ciba-Geigy to form Novartis, Sandoz Pharmaceuticals (Sandoz AG)

5076-530: The US outlawed residential use of diazinon when the EPA determined that its ability to damage the nervous system posed a risk to human health (especially the health of children). The chemical is still used for industrial agricultural purposes. According to the German Patent bureau, the industrial synthesis of diazinon is as follows: Diazinon functions as an acetylcholinesterase (AChE) inhibitor . This enzyme breaks down

5170-539: The United States in 2011, ~1400 cut positions in the United States in 2010, and a reduction of "thousands" and several site closures in previous years. Also in 2012, Novartis became the biggest manufacturer of generic skin care medicine, after agreeing to buy Fougera Pharmaceuticals for $ 1.525 billion in cash. In 2013, the Indian Supreme Court issued a decision rejecting Novartis' patent application in India on

5264-484: The chemist Paul Hermann Müller from the then-independent Geigy company had discovered that DDT was effective against malaria -bearing insects. This capability made use of DDT important enough that Müller even received the 1948 Nobel Prize in Medicine . However, as the decades following the award passed, DDT was found to be such an environmental danger that developed countries and eventually world-level organizations banned

5358-478: The company Bindschedler and Busch. In 1884, Bindschedler and Busch was transformed into a joint-stock company named " Gesellschaft für Chemische Industrie Basel " (Company for Chemical Industry Basel). The acronym , CIBA, was adopted as the company's name in 1945. The foundation for Geigy was established in 1857, when Johann Rudolf Geigy-Merian (1830–1917) and Johann Muller-Pack acquired a site in Basel, where they built

5452-453: The company acquired Encore Vision , gaining the company's principle compound, EV06, is a first-in-class topical therapy for presbyopia . In December Novartis acquired Ziarco Group Limited, bolstering its presence in eczema treatments. In late October 2017, Reuters announced that Novartis would acquire Advanced Accelerator Applications for $ 3.9 billion, paying $ 41 per ordinary share and $ 82 per American depositary share representing

5546-606: The company began producing agricultural chemicals. The psychedelic effects of lysergic acid diethylamide (LSD) were discovered at the Sandoz laboratories in 1943 by Arthur Stoll and Albert Hofmann . Sandoz began clinical trials and marketed the substance, from 1947 through the mid-1960s, under the name Delysid as a psychiatric drug, thought useful for treating a wide variety of mental ailments , ranging from alcoholism to sexual deviancy . Sandoz suggested in its marketing literature that psychiatrists take LSD themselves, to gain

5640-531: The company violated the False Claims Act and Anti-Kickback Statute by paying physicians to induce them to prescribe certain of the company's drugs. Novartis allegedly spent hundreds of millions of dollars on fraudulent speaker programs that served as a means to bribe doctors with cash payments and other extravagant rewards. Many of these speaking programs were allegedly nothing more than social gatherings at expensive restaurants, with limited or no discussion about

5734-665: The concept of toxicity endpoints. In Ancient Greek medical literature, the adjective τoξικόν (meaning "toxic") was used to describe substances which had the ability of "causing death or serious debilitation or exhibiting symptoms of infection." The word draws its origins from the Greek noun τόξον toxon (meaning "arc"), in reference to the use of bows and poisoned arrows as weapons. English-speaking American culture has adopted several figurative usages for toxicity , often when describing harmful inter-personal relationships or character traits (e.g. " toxic masculinity "). Humans have

SECTION 60

#1732855389165

5828-542: The deal, Cambrian was setting up a subsidiary called Tornado Therapeutics. In August 2022, the company announced its plan to spin off Sandoz generic drugs unit to form a publicly traded business as part of a restructuring. With the unit having generated US$ 9.69 billion in 2021, the spin-off would create the biggest generic drugs company in Europe by sales. In June 2023, Novartis announced it would acquire Chinook Therapeutics and its drug pipeline for up to $ 3.5 billion. In July 2023, Novartis acquired DTx Pharma,

5922-537: The drug from the market in 1965. The drug became a cultural novelty of the 1960s after psychologist Timothy Leary at Harvard University began to promote its use for recreational and spiritual experiences among the general public. Sandoz opened its first foreign offices in 1964. In 1967, Sandoz merged with Wander AG (known for Ovomaltine and Isostar ). Sandoz acquired the companies Delmark , Wasabröd (a Swedish manufacturer of crisp bread ), and Gerber Products Company (a baby food company). On 1 November 1986,

6016-775: The effective toxicity is then a combination. In some cases, e.g. cholera toxin , the disease is chiefly caused by a nonliving substance secreted by the organism, rather than the organism itself. Such nonliving biological toxicants are generally called toxins if produced by a microorganism, plant, or fungus, and venoms if produced by an animal. Physical toxicants are substances that, due to their physical nature, interfere with biological processes. Examples include coal dust, asbestos fibres or finely divided silicon dioxide , all of which can ultimately be fatal if inhaled. Corrosive chemicals possess physical toxicity because they destroy tissues, but are not directly poisonous unless they interfere directly with biological activity. Water can act as

6110-528: The elimination of diazinon from aqueous solutions. The removal of organophosphates (OPE) from water by adsorption techniques is regarded as one of the competitive methods because of its simple operation and low cost. Development of new adsorbents with high adsorption capacities is very important for removal of the OPE pollutants in the environment. Banning of Diazinon During the Clinton Era, President Clinton signed

6204-460: The entire body, lethality to specific organs, major/minor damage, or cause cancer. These are globally accepted definitions of what toxicity is. Anything falling outside of the definition cannot be classified as that type of toxicant. Acute toxicity looks at lethal effects following oral, dermal or inhalation exposure. It is split into five categories of severity where Category 1 requires the least amount of exposure to be lethal and Category 5 requires

6298-419: The environment. These hazards can be physical or chemical, and present in air, water, and/or soil. These conditions can cause extensive harm to humans and other organisms within an ecosystem. The EPA maintains a list of priority pollutants for testing and regulation. Workers in various occupations may be at a greater level of risk for several types of toxicity, including neurotoxicity. The expression "Mad as

6392-572: The example of well-established toxicity class systems and toxicity labels . While currently many countries have different regulations regarding the types of tests, numbers of tests and cut-off levels, the implementation of the Globally Harmonized System has begun unifying these countries. Global classification looks at three areas: Physical Hazards (explosions and pyrotechnics), Health Hazards and environmental hazards . The types of toxicities where substances may cause lethality to

6486-406: The extremities); however, reports of these symptoms following diazinon exposures are rare. Human who have been poisoned show increased levels of serum amylase and glucose as well as elevated urinary diastase levels accompanied by symptoms considered to be indicative of acute pancreatitis . A study found that 10% of 21 typically developing children show 2-isopropyl-6-methyl-4-pyrimidinol (IMPy,

6580-470: The final form of Gleevec , Novartis's cancer drug; the case caused great controversy. In 2013, Novartis was sued again by the US government, this time for allegedly bribing doctors for a decade so that their patients are steered towards the company's drugs. In January 2014, Novartis announced plans to cut 500 jobs from its pharmaceuticals division. In February 2014, Novartis announced that it acquired CoStim Pharmaceuticals. In May 2014, Novartis purchased

6674-433: The genetic makeup of an individual, an individual's overall health, and many others. Several of the terms used to describe these factors have been included here. Considering the limitations of the dose-response concept, a novel Abstract Drug Toxicity Index (DTI) has been proposed recently. DTI redefines drug toxicity, identifies hepatotoxic drugs, gives mechanistic insights, predicts clinical outcomes and has potential as

6768-515: The insecticide for all purposes except for combating disease-vector insects, leading Ciba-Geigy to research alternatives. Diazinon became available for mass use in 1955, while DDT production tapered. Before 1970, diazinon had issues with contaminants in its solution ; but by the 1970s, alternative purification methods were used to reduce the residual, unwanted materials. After this processing improvement, diazinon became an all-purpose, indoor-and-outdoor, commercial pest control product. In 2004,

6862-494: The lead compound AVXS-101 used to treat spinal muscular atrophy . In August 2018, Novartis signed a deal with Laekna-a Shanghai-based pharmaceutical company for its two clinical-stage cancer drugs. Novartis gave Laekna the exclusive international rights for the drugs that are oral pan-Akt kinase inhibitors namely; afuresertib (ASB138) and uprosertib (UPB795). In mid-October, the company announced it would acquire Endocyte Inc for $ 2.1 billion ($ 24 per share) merging it with

6956-406: The most exposure to be lethal. The table below shows the upper limits for each category. Note: The undefined values are expected to be roughly equivalent to the category 5 values for oral and dermal administration. Skin corrosion and irritation are determined through a skin patch test analysis, similar to an allergic inflammation patch test . This examines the severity of the damage done; when it

7050-409: The neurotransmitter acetylcholine (ACh) into choline and an acetate group. The inhibition of AChE causes an abnormal accumulation of ACh in the synaptic cleft . When diazinon enters the body, it is oxidatively decomposed to diazoxon, an organophosphate compound that is much more poisonous than diazinon; it mainly causes the inhibition of AChE. The conversion of diazinon to diazoxon (Reaction 1)

7144-614: The other hand, in regard to chronic toxicity , the WHO/FAO joint committee on pesticide residues gives the admissible daily intake (ADI) to be 0.005 mg/kg of body weight, while the Australian Pesticides and Veterinary Medicine authority gives the no-observed-adverse-effect-level (NOAEL) to be 0.02 mg/kg of body weight for adults. Intoxication of diazinon produces the following signs and symptoms: Typically treatments will vary depending on exposure and method of administration of

7238-451: The pharmaceutical and agrochemical divisions of both staying together to form Novartis. Other Ciba-Geigy and Sandoz businesses were spun off as independent companies. notably Ciba Specialty Chemicals . Sandoz's Master Builders Technologies, a producer of chemicals for the construction industry, was sold off to SKW Trostberg A.G., a subsidiary of the German energy company VIAG , while its North American corn herbicide business became part of

7332-544: The practice of making poison arrows was widespread in cultures as early as the paleolithic era. The San people of Southern Africa have managed to preserved this practice into the modern era, with the knowledge base to form complex mixtures from poisonous beetles and plant derived extracts, yielding an arrow-tip product with a shelf life beyond several months to a year. There are generally five types of toxicities: chemical, biological, physical, radioactive and behavioural. Disease-causing microorganisms and parasites are toxic in

7426-462: The rights to market Ophthotech 's Fovista (an anti- PDGF aptamer , also being investigated for use in combination with anti- VEGF treatments) outside the U.S. for up to $ 1 billion. Novartis acquired exclusive rights to market the eye drug outside of the states while retaining U.S. marketing rights. The company agreed to pay Ophthotech $ 200 million upfront, and $ 130 million in milestone payments relating to Phase III trials. Ophthotech

7520-406: The skin, ingested, inhaled, injected), the time of exposure (a brief encounter or long term), the number of exposures (a single dose or multiple doses over time), the physical form of the toxicant (solid, liquid, gas), the concentration of the substance, and in the case of gases, the partial pressure (at high ambient pressure, partial pressure will increase for a given concentration as a gas fraction),

7614-456: The species-, organ- and dose-specific toxic effects of an investigational product. The toxicity of substances can be observed by (a) studying the accidental exposures to a substance (b) in vitro studies using cells/ cell lines (c) in vivo exposure on experimental animals. Toxicity tests are mostly used to examine specific adverse events or specific endpoints such as cancer, cardiotoxicity, and skin/eye irritation. Toxicity testing also helps calculate

7708-954: The spin-off had been approved by its shareholders and that it would be completed by the next month, resulting in Novartis shareholders receiving one Sandoz share for every five Novartis shares. Sandoz will be listed on the SIX Swiss Exchange with a market capitalization between $ 18 billion and $ 25bn. On 4 October 2023, Novartis completed the spin-off of Sandoz as a stand-alone company. In November 2023, Legend Biotech and Novartis signed an out-license deal to develop and manufacture Legend's chimeric antigen receptor (CAR-T) therapies, that go after delta-like ligand protein 3 (DLL3) including large cell neuroendocrine carcinoma candidate LB2102 for $ 100 million upfront, and Legend Biotech will be eligible to receive up to $ 1.01 billion in clinical, regulatory, and commercial milestone payments and tiered royalties. Toxicity Toxicity

7802-460: The spin-off of Alcon as a separate commercial entity. Alcon was listed on the SIX exchange in Switzerland and NYSE exchange in the U.S. Novartis announced during late 2019 a five-year artificial intelligence "alliance" with Microsoft. The companies aim to create applications for "Microsoft's AI capabilities", in turn improving the other's drug development processes. Microsoft seeks to "test AI products it

7896-508: The toxin. Critical biomarkers such as urine samples, blood content and heart rates are measured while detoxifying the patient. Common treatments for patients with diazinon poisoning include: Patients that continue to improve over the first 4 to 6 hours (after medical treatment) usually recover unscathed. Prolonged treatment often is needed to reverse the poisoning, including intensive care hospitalization and long-term therapy. Some toxicity may persist for weeks or months, or even longer. Diazinon

7990-463: The world's largest eye-care company, including a majority stake held by Nestlé. Novartis had bought 25 percent of Alcon in 2008. Novartis created a new division and called it Alcon, under which it placed its CIBA VISION subsidiary and Novartis Ophthalmics, which became the second-largest division of Novartis. The total cost for Alcon amounted to $ 60 billion. In 2011, Novartis acquired the medical laboratory diagnostics company Genoptix to "serve as

8084-448: Was a pharmaceutical company headquartered in Basel , Switzerland (as was Ciba-Geigy), and was best known for developing drugs such as Sandimmune for organ transplantation , the antipsychotic Clozaril , Mellaril Tablets and Serentil Tablets for treating psychiatric disorders , and Cafergot Tablets and Torecan Suppositories for treating migraine headaches . The Chemiefirma Kern und Sandoz ("Kern and Sandoz Chemistry Firm")

8178-417: Was created in 20 December 1996 from the merger of Ciba-Geigy and Sandoz Laboratories, both Swiss companies. Ciba-Geigy was formed in 1970 by the merger of J. R. Geigy Ltd (founded in Basel in 1857) and CIBA (founded in Basel in 1859). Ciba began in 1859, when Alexander Clavel (1805–1873) took up the production of fuchsine in his factory for silk -dyeing works in Basel. By 1873, he sold his dye factory to

8272-565: Was formed in 1996 by the merger of Ciba-Geigy and Sandoz . It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, “novae artes” (new skills). After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals , spun off as independent companies. The Sandoz brand disappeared for three years, but

8366-489: Was founded in 1886 by Alfred Kern (1850–1893) and Edouard Sandoz (1853–1928). The first dyes manufactured by them were alizarinblue and auramine . After Kern's death, the partnership became the corporation Chemische Fabrik vormals Sandoz in 1895. The company began producing the fever-reducing drug antipyrin in the same year. In 1899, the company began producing the sugar substitute saccharin . Further pharmaceutical research began in 1917 under Arthur Stoll (1887–1971), who

8460-446: Was identified. The following year, a discharge pipe was shut down after a sinkhole at the corner of Bay Avenue and Vaughn Avenue revealed that it had been leaking. The plant ceased operation in 1996. A follow-up study from the 1996–2000 period indicated that while there were more cancer cases than expected, rates had significantly fallen and the difference was statistically insignificant compared to normal statewide cancer rates. Since 1996,

8554-524: Was imposed a fine of €385 million by the French competition authority on accusations of abusive practices to preserve sales of Lucentis over a cheaper drug. Also in September, BioNTech has leased a large production facility from Novartis to follow all advance demands for its coronavirus vaccine in Europe and sell it to China. In July 2020, Novartis agreed to pay $ 678 million to settle allegations that

8648-458: Was not always adequately realized. Lead and cadmium, among other toxic elements, were often incorporated into the names of artist's oil paints and pigments, for example, "lead white" and "cadmium red". 20th-century printmakers and other artists began to be aware of the toxic substances, toxic techniques, and toxic fumes in glues, painting mediums, pigments, and solvents, many of which in their labelling gave no indication of their toxicity. An example

8742-432: Was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Novartis divested its agrochemical and genetically modified crops business in 2000 with the spinout of Syngenta in partnership with AstraZeneca , which also divested its agrochemical business. The new company also acquired a series of acquisitions in order to strengthen its core businesses. Novartis

8836-448: Was the use of xylol for cleaning silk screens . Painters began to notice the dangers of breathing painting mediums and thinners such as turpentine . Aware of toxicants in studios and workshops, in 1998 printmaker Keith Howard published Non-Toxic Intaglio Printmaking which detailed twelve innovative Intaglio -type printmaking techniques including photo etching , digital imaging , acrylic -resist hand-etching methods, and introducing

#164835